United Therapeutics board OKs new share repurchase

SILVER SPRING — United Therapeutics Corp. said Monday that its board of directors approved a plan to buy back an additional $420 million of the drug developer’s stock. The Silver Spring company said the program will become effective March 4 and remain open for up to a year. United Therapeutics finished a $100 million share [...]

E-Mail Newsroom


Comments

Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • HTML tags will be transformed to conform to HTML standards.

More information about formatting options

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.